{"id":"W2158927044","doi":"10.1158/1078-0432.ccr-11-3284","title":"A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report","year":2012,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Sorafenib; Rash; Pharmacokinetics; Tolerability; Response Evaluation Criteria in Solid Tumors; Internal medicine; Pharmacodynamics; Refractory (planetary science); Adverse effect; Gastroenterology; Oncology; Pharmacology; Toxicity; Phases of clinical research; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003834675,0.000247421,0.00119401,0.0003708278,0.00009047925,0.00001675531,0.0001579462,0.0001748141,0.0003297619],"category_scores_gemma":[0.001058826,0.0001595981,0.0001056517,0.0006071675,0.0006644966,0.0001155248,0.0001579651,0.001094254,0.000006600514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000359344,"about_ca_system_score_gemma":0.00114478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00161754,"about_ca_topic_score_gemma":0.0004103959,"domain_scores_codex":[0.995411,0.0009233162,0.001391345,0.0006876331,0.0008355962,0.0007510529],"domain_scores_gemma":[0.9970867,0.001076734,0.0003731944,0.0005583957,0.0002427231,0.0006622629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1434098,0.09571054,0.7139347,0.00003123399,0.0007636181,0.001518367,0.0004470636,0.000001045262,0.0003174046,0.000003119835,0.0009151756,0.04294793],"study_design_scores_gemma":[0.5064087,0.08314095,0.4070063,0.0001635488,0.0005239578,0.0006034059,0.0005456479,0.00001650371,0.0007153207,0.000003027499,0.0006816221,0.0001910619],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927955,0.001447697,8.968419e-7,0.0002777174,0.0001518194,0.005144479,0.00003579117,0.00002356682,0.0001225638],"genre_scores_gemma":[0.9966772,0.0009499222,0.00004608845,0.0001009245,0.0008237135,0.001254924,0.00004596944,0.00004253552,0.0000587849],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3629989,"threshold_uncertainty_score":0.6508222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2109089383653876,"score_gpt":0.5746474152749125,"score_spread":0.3637384769095249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}